Incyte Corp [INCY] stock prices are up 1.44% to $69.23 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The INCY shares have gain 0.74% over the last week, with a monthly amount glided 2.18%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Incyte Corp [NASDAQ: INCY] stock has seen the most recent analyst activity on June 16, 2025, when Stifel upgraded its rating to a Buy but kept the price target unchanged to $107 for it. Previously, William Blair downgraded its rating to Mkt Perform on March 18, 2025. On March 18, 2025, downgrade downgraded it’s rating to Neutral. UBS started tracking the stock assigning a Neutral rating and suggested a price target of $77 on December 17, 2024. BofA Securities upgraded its rating to a Buy and raised its price target to $90 on October 29, 2024. Wolfe Research started tracking with a Outperform rating for this stock on October 01, 2024, and assigned it a price target of $84. In a note dated September 18, 2024, Truist downgraded an Hold rating on this stock and revised its target price from $83 to $74.
The stock price of Incyte Corp [INCY] has been fluctuating between $53.56 and $83.95 over the past year. Currently, Wall Street analysts expect the stock to reach $79.5 within the next 12 months. Incyte Corp [NASDAQ: INCY] shares were valued at $69.23 at the most recent close of the market. An investor can expect a potential return of 14.83% based on the average INCY price forecast.
Analyzing the INCY fundamentals
The Incyte Corp [NASDAQ:INCY] reported sales of 4.41B for trailing twelve months, representing a surge of 19.53%. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.01 and Total Capital is 0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 68.45 points at the first support level, and at 67.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 69.72, and for the 2nd resistance point, it is at 70.20.
Ratios To Look Out For
It’s worth pointing out that Incyte Corp [NASDAQ:INCY]’s Current Ratio is 2.04. Further, the Quick Ratio stands at 2.00, while the Cash Ratio is 1.13. Considering the valuation of this stock, the price to sales ratio is 3.04, the price to book ratio is 3.66 and price to earnings (TTM) ratio is 214.20.
Transactions by insiders
Recent insider trading involved VIJAY IYENGAR, Officer, that happened on Jul 16 ’25 when 983.0 shares were purchased. Officer, BARRY FLANNELLY completed a deal on Jul 16 ’25 to buy 1340.0 shares. Meanwhile, EVP & Chief Medical Officer Stein Steven H sold 14952.0 shares on Jul 14 ’25.
